Dexmedetomidine Improves Lung Function by Promoting Inflammation Resolution in Patients Undergoing Totally Thoracoscopic Cardiac Surgery
Table 1
Demographic characteristics of participants in the two groups.
Con group ()
DEX group ()
value
Age (y)
0.625
Sex (male/female)
16/12
18/11
0.705
Body mass index (kg/m2)
0.722
NYHA classification, (%)
0.669
II
26 (92.9)
26 (89.7)
III
2 (7.7)
3 (10.3)
LVEF (%)
0.286
PASP (mmHg)
0.148
Duration of CPB (min)
0.888
Aortic cross-clamping (min)
0.265
Operation type, (%)
0.760
MVR
4 (14.3)
5 (82.8)
MVP
24 (85.7)
24 (17.2)
Comorbidities, (%)
Grade 3 hypertension
2 (7.7)
3 (10.3)
0.669
Diabetes mellitus
2 (7.1)
1 (3.4)
0.532
Atrial fibrillation
7 (25.0)
5 (17.2)
0.473
Quantitative data are presented as or numbers (percentages). NYHA: New York Heart Association; PASP: pulmonary artery systolic pressure; LVEF: left ventricular ejection fraction; MVR: mitral valve replacement; MVP: mitral valvuloplasty.
